References
- Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2020. [cited 2023 Feb 28]. Available at:
https://gco.iarc.fr/today - ECIS - European Cancer Information System. © European Union. 2023. [cited 2023 Feb 28]. Available at:
https://ecis.jrc.ec.europa.eu - Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47–55. doi: 10.1515/raon-2017-0008
- Statistical Office of the Republic of Slovenia. [cited 2023 Feb 12]. Available at:
www.stat.si - Winters S, Martin C, Murphy D, Shokar NK. Breast cancer epidemiology, prevention and screening. Prog Mol Biol Transl Sci 2017; 151: 1–32. doi: 10.1016/bs.pmbts.2017.07.002
- Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, Widschwendter M, et al. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol 2020; 17: 687–705. doi: 10.1038/s41571-020-0388-9
- World Health Organization, International Agency for Research on Cancer. IARC handbooks of cancer prevention. Volume 15. Breast Cancer Screening. Lyon: IARC; 2016.
- European Commission Initiative on Breast Cancer; 2023. [cited 2023 May 2]. Available at:
https://healthcare-quality.jrc.ec.europa.eu/ecibc - Council Recommendation on strengthening prevention through early detection: a new EU approach on cancer screening replacing Council Recommendation 2003/878/EC. 2022/0290(NLE). Brussels: Council of the European Union; 2022. [cited 2023 May 2]. Available at:
https://ec.europa.eu/commission/presscorner/detail/en/ip_22_7548 - Canelo-Aybar C, Ferreira DS, Ballesteros M, Posso M, Montero N, Sola I, et al. Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer. J Med Screen 2021; 28: 389–404. doi: 10.1177/0969141321993866
- Román M, Sala M, Domingo L, Posso M, Louro J, Castells X. Personalized breast cancer screening strategies: a systematic review and quality assessment. PLoS One 2019; 14: e0226352. doi: 10.1371/journal.pone.0226352
- Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999; 91: 1541–8. doi: 10.1093/jnci/91.18.1541
- Tice JA, Bissell MCS, Miglioretti DL, Gard CC, Rauscher GH, Dabbous FM, et al. Validation of the breast cancer surveillance consortium model of breast cancer risk. Breast Cancer Res Treat 2019; 175: 519–23. doi: 10.1007/s10549-019-05167-2
- Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004; 23: 1111–30. doi: 10.1002/sim.1668
- Lee A, Mavaddat N, Cunningham A, Carver T, Ficorella L, Archer S, et al. Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence. J Med Genet 2022; 59: 1206–18. doi: 10.1136/jmedgenet-2022-108471
- Carver T, Hartley S, Lee A, Cunningham AP, Archer S, Babb de Villiers C, et al. CanRisk Tool - a web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants. Cancer Epidemiol Biomarkers Prev 2021; 30: 469–73. doi: 10.1158/1055-9965.EPI-20-1319
- Jarm K, Kadivec M, Šval C, Hertl K, Primic Žakelj M, Dean PB, et al. Quality assured implementation of the Slovenian breast cancer screening programme. PLoS One 2021; 16: e0258343. doi: org/10.1371/journal.pone.0258343
- Blatnik A, Perhavec A, Gazić B, Vidergar-Kralj B, Matos E, Ratoša I, et al. [Recommendations for diagnosis and treatment of patients with breast cancer 2021]. [Slovenian]. Digital repository of Slovenian research organizations. Institute of Oncology Ljubljana. ISBN 978-961-7029-42-0. [cited 2023 Jan 21]. Available at:
https://dirros.openscience.si/IzpisGradiva.php?lang=slv&id=14846 - Zadnik V, Krajc M. [Development and implementation of personalised breast cancer risk evaluation tool for Slovenian population]. [Slovenian]. Onkologija 2018; 22: 6–10. doi: 10.25670/oi2018-016on
- Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, et al, editors. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition. Luxembourg: European Commission. Office for Official Publications of the European Communities; 2006.
- Krajc M, Blatnik A, Kerševan T, Hotujec S. [Clinical pathway for patients’ care at the Department of clinical cancer genetics]. [Slovenian]. Ljubljana: Institute of Oncology Ljubljana. [cited: 2023 May 15]. Available at:
https://www.onko-i.si/fileadmin/onko/datoteke/Strokovna_knjiznica/klinicne_poti/Klinicna_pot_obravnave_pacienta_v_Ambulanti_za_onkolosko_genetsko_svetovanje_in_testiranje_2020.pdf - Sickles EA, D’Orsi CJ, Bassett LW. ACR BI-RADS® mammography. In: ACR BI-RADS® Atlas. Breast imaging reporting and data system. Reston, VA: American College of Radiology; 2013.
- World Health Organization. Menopause. [cited 2023 June 21]. Available at:
https://www.who.int/news-room/fact-sheets/detail/menopause#:~:text=Most%20women%20experience%20menopause%20between,changes%20in%20the%20menstrual%20cycle - Brentnall AR, Cuzick J. Risk models for breast cancer and their validation. Stat Sci 2020; 35: 14–30. doi: 10.1214/19-STS729
- Krajc M, Evans GD, Blatnik A, Lokar K, Žagar T, Tomšič S, et al. Screening strategy modification based on personalized breast cancer risk stratification and its implementation in the national guidelines - pilot study. Zdr Varst 2020; 18: 211–18. doi: 10.2478/sjph-2020-0027
- IBIS breast cancer evaluation tool. [cited: 2023 April 10]. Available at:
https://ems-trials.org/riskevaluator/ - Evans DG, Astley S, Stavrinos P, Harkness E, Donnelly LS, Dawe S, et al. Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study. Southampton, UK: NIHR Journals Library; 2016. doi: 10.3310/pgfar04110
- Roux A, Cholerton R, Sicsic J, Moumjid N, French DP, Rossi PG, et al. Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial. BMC Cancer 2022; 22: 507. doi: 10.1186/s12885-022-09484-6
- Evans DG, Donnelly LS, Harkness EF, Astley SM, Stavrinos P, Dawe S, et al. Breast cancer risk feedback to women in the UK NHS breast screening population. Br J Cancer 2016; 114: 1045–52. doi: 10.1038/bjc.2016.56
- Laza-Vásquez C, Martínez-Alonso M, Forné-Izquierdo C, Vilaplana-Mayoral J, Cruz-Esteve I, Sánchez-López I, et al. DECIDO Group. Feasibility and acceptability of personalized breast cancer screening (DECIDO Study): a single-arm proof-of-concept trial. Int J Environ Res Public Health 2022; 19: 10426. doi: 10.3390/ijerph191610426
- Simonović S, Zadnik V, Hafner A. [Pilot testing of individual breast cancer risk tool at Breast centre Kranj]. [Slovenian]. Graduation thesis. Ljubljana: University of Ljubljana; 2017. [cited: 2023 March 20]. Available at:
https://plus.cobiss.net/cobiss/si/sl/bib/2883451 - Oblak T, Zadnik V, Krajc M, Lokar K, Zgajnar J. Breast cancer risk based on adapted IBIS prediction model in Slovenian women aged 40–49 years - could it be better? Radiol Oncol 2020; 54: 335–40. doi: 10.2478/raon-2020-0040
- University Hospital of South Manchester. Genesis breast cancer prevention centre. Research overview 2014/15. Manchester: NHS Foundation trust; 2015. [cited: 2023 May 1]. Available at:
http://www.breastcentre.manchester.ac.uk/Portals/12/Documents/Genesis%20Research%20Overview%202015.pdf - Esserman LJ; WISDOM Study and Athena Investigators. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer 2017; 3: 34. doi: 10.1038/s41523-017-0035-5
- My personal breast screening (MyPeBS). US National Library of Medicine. ClinicalTrials.gov ID NCT03672331. [cited: 2023 March 22]. Available at:
https://clinicaltrials.gov/ct2/show/record/NCT03672331 - National Institute for Health and Care Excellence. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer CG164. NICE; 2013. [cited: 2023 March 1]. Available at:
https://www.nice.org.uk/guidance/cg164/chapter/Recommendations#surveillance-and-strategies-for-early-detection-of-breast-cancer - Augustinsson A, Ellberg C, Kristoffersson U, Borg Å, Olsson H. Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer. Acta Oncol 2018; 57: 595–603. doi: 10.1080/0284186X.2017.1404635
- National Institute of Public Health. Data portal. [cited 2023 June 20]. Available at:
https://podatki.nijz.si/pxweb/sl/NIJZ%20podatkovni%20portal/?rxid=9e76cdb9-ec30-4a1a-a1c4-9fce467492a8 - Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356: 227–36. doi: 10.1056/NEJMoa062790
- Checka CM Chun JE, Freya SR, Lee J, Toth H. The relationship of mammographic density and age: implications for breast cancer screening. AJR 2012; 198: 292–5. doi: 10.2214/AJR.10.6049
- Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2016; 106: 255. doi: 10.1093/jnci/dju255
- Portnow LH, Georgian-Smith D, Haider I, Barrios M, Camden P, Bay CP, et al. Persistent inter-observer variability of breast density assessment using BI-RADS® 5th edition guidelines. Clinical Imaging 2022; 83: 21–7. doi: 10.1016/j.clinimag.2021.11.034
- Brentnall AR, Harkness EF, Astley SM, Donnelly LS, Stavrinos P, Sampson S. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Breast Cancer Res 2015; 17: 147. doi: 10.1186/s13058-015-0653-5
- A short guide to cancer screening: increase effectiveness, maximize benefits and minimize harm. World Health Organization. Regional Office for Europe; 2022. [cited: 2023 May 1]. Available at:
https://apps.who.int/iris/handle/10665/351396 - Di Stefano F, Camussi E, Casnati G, Garena F, Ceresa M, Castagno R, et al. Communication of breast cancer risk and a personalized screening protocol: experience within the MyPeBS Study. [abstract]. Code: ICS18011-74. International Cancer Screening Network conference. Turin; 2023.
- Kurir Borovčić M, Jarm K, Kutnar V, Škrbec V, Torkar K, Šval C, et al. Programme DORA yearly report of 2021. [Slovenian]. Ljubljana: Institute of Oncology Ljubljana; 2022. [cited 2023 April 20]. Available at:
https://dora.onko-i.si/fileadmin/user_upload/Dokumenti/DORA_Letno_porocilo_2021_WEB_apr_2022.pdf